Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 12 INDUSTRY 5 FED 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Thoracic Neoplasms 1 Sarcopenia 1 Recurrence 1 Rectal Neoplasms 1 Rare Diseases 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neurologic Manifestations 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Myasthenia Gravis 1 Mental Disorders 1 Lung Neoplasms 1 Lung Diseases 1 Liver Neoplasms 1 Head and Neck Neoplasms 1 Early Stage Lung Cancer (I and II) 1 Condylomata Acuminata 1 Colonic Polyps 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Bronchogenic 1 Cachexia 1 Breast Neoplasms 1 Anxiety Disorders 1 Adenomatous Polyposis Coli 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × FED × Cachexia × Clear all

NCT01505764 2018-07-17

The Role of Ghrelin in Cancer Cachexia

VA Office of Research and Development

Phase 2 Terminated

10 enrolled 20 charts

Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡